These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8062205)

  • 21. Characterization by 32P-postlabelling of 8-methoxypsoralen adducts.
    Gillardeaux O; Perin-Rousel O; Perin F
    IARC Sci Publ; 1993; (124):133-9. PubMed ID: 8225476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered fidelity of a nucleic acid modifying enzyme, T4 polynucleotide kinase, by safrole-induced DNA damage.
    Randerath K; Gupta KP; van Golen KL
    Carcinogenesis; 1993 Aug; 14(8):1523-9. PubMed ID: 8102596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II).
    Bellon SF; Coleman JH; Lippard SJ
    Biochemistry; 1991 Aug; 30(32):8026-35. PubMed ID: 1868076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphodiester-mediated reaction of cisplatin with guanine in oligodeoxyribonucleotides.
    Campbell MA; Miller PS
    Biochemistry; 2008 Dec; 47(48):12931-8. PubMed ID: 18991396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.
    Reddy MV; Randerath K
    Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Escherichia coli DNA polymerase I: inherent exonuclease activities differentiate between monofunctional and bifunctional adducts of DNA and cis- or trans-diamminedichloroplatinum(II). An exonuclease investigation of the kinetics of the adduct formation.
    Bernges F; Dörner G; Holler E
    Eur J Biochem; 1990 Aug; 191(3):743-53. PubMed ID: 2167853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 32P-postlabelling approaches for the detection of 8-oxo-2'-deoxyguanosine-3'-monophosphate in DNA.
    Podmore K; Farmer PB; Herbert KE; Jones GD; Martin EA
    Mutat Res; 1997 Aug; 378(1-2):139-49. PubMed ID: 9288892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection and identification of benzo[a]pyrene-DNA adducts by [35S]phosphorothioate labeling and HPLC.
    Lau HH; Baird WM
    Carcinogenesis; 1991 May; 12(5):885-93. PubMed ID: 2029754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPLC-32P-postlabelling analysis of 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytidine.
    Watson WP; Crane AE
    Mutagenesis; 1989 Jan; 4(1):75-7. PubMed ID: 2654556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of phosphodiesterase I-based protocols for the detection of multiply damaged sites in DNA: the detection of abasic, oxidative and alkylative tandem damage in DNA oligonucleotides.
    Bowman KJ; Pla RL; Guichard Y; Farmer PB; Jones GD
    Nucleic Acids Res; 2001 Oct; 29(20):E101. PubMed ID: 11600720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications.
    Reddy MV; Randerath K
    Environ Health Perspect; 1987 Dec; 76():41-7. PubMed ID: 2834194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a 32P-postlabelling method for the analysis of adducts arising through the reaction of acetaldehyde with 2'-deoxyguanosine-3'-monophosphate and DNA.
    Fang JL; Vaca CE
    Carcinogenesis; 1995 Sep; 16(9):2177-85. PubMed ID: 7554072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of malonaldehyde-modified 2'-deoxyguanosine-3'-monophosphate and DNA by 32P-postlabelling.
    Vaca CE; Vodicka P; Hemminki K
    Carcinogenesis; 1992 Apr; 13(4):593-9. PubMed ID: 1576712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SVPD-post-labeling detection of oxidative damage negates the problem of adventitious oxidative effects during 32P-labeling.
    Jones GD; Dickinson L; Lunec J; Routledge MN
    Carcinogenesis; 1999 Mar; 20(3):503-7. PubMed ID: 10190569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical and biological studies of the major DNA adduct of cis-diamminedichloroplatinum(II), cis-[Pt(NH3)2(d(GpG]], built into a specific site in a viral genome.
    Naser LJ; Pinto AL; Lippard SJ; Essigmann JM
    Biochemistry; 1988 Jun; 27(12):4357-67. PubMed ID: 3166983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
    Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A
    IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical versatility of transplatin monofunctional adducts within multiple site-specifically platinated DNA.
    Bernal-Méndez E; Boudvillain M; González-Vilchez F; Leng M
    Biochemistry; 1997 Jun; 36(24):7281-7. PubMed ID: 9200676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 32P-postlabelling and mass spectrometric methods for analysis of bulky, polyaromatic carcinogen-DNA adducts in humans.
    Talaska G; Roh JH; Getek T
    J Chromatogr; 1992 Sep; 580(1-2):293-323. PubMed ID: 1400827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 32P-postlabelling analysis of small aromatic and of bulky non-aromatic DNA adducts.
    Reddy MV
    IARC Sci Publ; 1993; (124):25-34. PubMed ID: 8225492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 32P-postlabeling detection of radiation-induced DNA damage: identification and estimation of thymine glycols and phosphoglycolate termini.
    Weinfeld M; Soderlind KJ
    Biochemistry; 1991 Jan; 30(4):1091-7. PubMed ID: 1846559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.